Motor function performance in individuals with RYR1-related myopathies

被引:6
|
作者
Witherspoon, Jessica W. [1 ]
Vuillerot, Carole [2 ,3 ,4 ]
Vasavada, Ruhi P. [5 ]
Waite, Melissa R. [5 ]
Shelton, Monique [1 ]
Chrismer, Irene C. [1 ]
Jain, Minal S. [5 ]
Meilleur, Katherine G. [1 ]
机构
[1] NINR, NIH, Bethesda, MD 20892 USA
[2] Hosp Civils Lyon, Hop Femme Mere Enfant, Escale, Serv Med Phys & Readaptat Pediat, F-69500 Bron, France
[3] Univ Lyon, F-69000 Lyon, France
[4] Univ Lyon 1, F-69100 Villeurbanne, France
[5] NIH, Rehabil Med, Bldg 10, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
disease progression; GFT; MFM; motor function; RYR1; DUCHENNE MUSCULAR-DYSTROPHY; CONGENITAL MYOPATHIES; RYR1;
D O I
10.1002/mus.26491
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction The objective of this study was to obtain a 6-month natural history of motor function performance in individuals with RYR1- related myopathy (RYR1-RM) by using the Motor Function Measure-32 (MFM-32) and graded functional tests (GFT) while facilitating preparation for interventional trials. Methods In total, 34 participants completed the MFM-32 and GFTs at baseline and 6-month visits. Results Motor deficits according to MFM-32 were primarily observed in the standing and transfers domain (D1; mean 71%). Among the GFTs, participants required the most time to ascend/descend stairs (>7.5 s). Functional movement, determined by GFT grades, was strongly correlated with MFM-32 (D1; r >= 0.770, P < 0.001). Motor Function Measure-32 and GFT scores did not reflect any change in performance between baseline and 6-month visits. Discussion The MFM-32 and GFTs detected motor impairment in RYR1-RM, which remained stable over 6 months. Thus, these measures may be suitable for assessing change in motor function in response to therapeutic intervention. Muscle Nerve 60: 80-87, 2019
引用
收藏
页码:80 / 87
页数:8
相关论文
共 50 条
  • [31] Identifying new therapies for RYR1-related myopathies using a novel drug discovery pipeline
    Volpatti, J.
    Burns, A.
    Davidson, A. E.
    Roy, P.
    Dowling, J. J.
    NEUROMUSCULAR DISORDERS, 2014, 24 (9-10) : 808 - 808
  • [32] Muscle Ultrasound Abnormalities in Individuals with RYR1-Related Malignant Hyperthermia Susceptibility
    van den Bersselaar, Luuk R.
    van Alfen, Nens
    Kruijt, Nick
    Kamsteeg, Erik-Jan
    Fernandez-Garcia, Miguel A.
    Treves, Susan
    Riazi, Sheila
    Yang, Chu-Ya
    Malagon, Ignacio
    van Eijk, Lucas T.
    van Engelen, Baziel G. M.
    Scheffer, Gert-Jan
    Jungbluth, Heinz
    Snoeck, Marc M. J.
    Voermans, Nicol C.
    JOURNAL OF NEUROMUSCULAR DISEASES, 2023, 10 (04) : 541 - 554
  • [33] Systemic NAD plus deficiency reveals a potential therapeutic target for RYR1-related myopathies
    Lawal, T.
    Riekhof, W.
    Groom, L.
    Varma, P.
    Chrismer, I.
    Kokkinis, A.
    Grunseich, C.
    Witherspoon, J.
    Razaqyar, M.
    Meilleur, K.
    Bonnemann, C.
    Xiang, L.
    Euro, L.
    Jansson, S.
    Mohassel, P.
    Dirksen, R.
    Todd, J.
    NEUROMUSCULAR DISORDERS, 2023, 33 : S128 - S128
  • [34] Qualitative comparison of healthy versus affected muscles by ultrasound imaging in RYR1-related myopathies
    Razaqyar, M.
    Butrum, J.
    Witherspoon, J.
    Tounkara, F.
    Shelton, M.
    Elliott, J.
    Arveson, I.
    Meilleur, K.
    NEUROMUSCULAR DISORDERS, 2016, 26 : S98 - S98
  • [35] Understanding Symptoms in RYR1-Related Myopathies: A Mixed-Methods Analysis Based on Participants’ Experience
    Carlos Capella-Peris
    Mary M. Cosgrove
    Irene C. Chrismer
    M. Sonia Razaqyar
    Jeffrey S. Elliott
    Anna Kuo
    Magalie Emile-Backer
    Katherine G. Meilleur
    The Patient - Patient-Centered Outcomes Research, 2020, 13 : 423 - 434
  • [36] Understanding Symptoms in RYR1-Related Myopathies: A Mixed-Methods Analysis Based on Participants' Experience
    Capella-Peris, Carlos
    Cosgrove, Mary M.
    Chrismer, Irene C.
    Razaqyar, M. Sonia
    Elliott, Jeffrey S.
    Kuo, Anna
    Emile-Backer, Magalie
    Meilleur, Katherine G.
    PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2020, 13 (04): : 423 - 434
  • [37] Cohort of Czech patients with RYR1-related disorders
    Lauerova, B.
    Zidkova, J.
    Rohlenova, M.
    Dolanska, A.
    Gloser, M.
    Kumhera, M.
    Lassuthova, P.
    Kramarova, T.
    Kopcilova, J.
    Fajkusova, L.
    Haberlova, J.
    NEUROMUSCULAR DISORDERS, 2024, 43
  • [38] Mixed methods analysis of Health-Related Quality of Life in ambulant individuals affected with RYR1-related myopathies pre-post-N-acetylcysteine therapy
    Carlos Capella-Peris
    Mary M. Cosgrove
    Irene C. Chrismer
    Magalie Emile-Backer
    M. Sonia Razaqyar
    Jeffrey S. Elliott
    Anna Kuo
    Paul G. Wakim
    Katherine G. Meilleur
    Quality of Life Research, 2020, 29 : 1641 - 1653
  • [39] Mixed methods analysis of Health-Related Quality of Life in ambulant individuals affected with RYR1-related myopathies pre-post-N-acetylcysteine therapy
    Capella-Peris, Carlos
    Cosgrove, Mary M.
    Chrismer, Irene C.
    Emile-Backer, Magalie
    Razaqyar, M. Sonia
    Elliott, Jeffrey S.
    Kuo, Anna
    Wakim, Paul G.
    Meilleur, Katherine G.
    QUALITY OF LIFE RESEARCH, 2020, 29 (06) : 1641 - 1653
  • [40] Dantrolene as a treatment option for RYR1-related rhabdomyolysis
    Scalco, R.
    Voermans, N.
    Piercy, R.
    Jungbluth, H.
    Quinlivan, R.
    NEUROMUSCULAR DISORDERS, 2016, 26 : S136 - S136